COVID-19 patients have been reported to develop thrombotic complications.
Portal vein thrombosis is known to be associated with COVID-19.
Anticoagulation in patients with a risk of bleeding needs to be carefully considered.
Keywords: Anticoagulation; COVID-19; Portal vein thrombosis; SARS-CoV-2.